SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Genaera Pharmaceuticals - antibiotics, cancer, asthma

No earlier versions found for this Subject.


Return to Genaera Pharmaceuticals - antibiotics, cancer, asthma
 
Earnings out. Phase 2 in antiangiogenesis for ovarian cancer going well. Income coming in from Asthma IL-9 trials. How long before FDA approval?

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News